Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Suda Ltd - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 32 | Code: MRS - 18621

Global Markets Directs, Suda Ltd Product Pipeline Review 2014, provides an overview of the Suda Ltds pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Suda Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


The report provides brief overview of Suda Ltd including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Suda Ltds human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Suda Ltds pipeline products

Reasons to buy

Evaluate Suda Ltds strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Suda Ltd in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Suda Ltds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Suda Ltd and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Suda Ltd
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Suda Ltd and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content

Table of Contents 2
List of Tables 4
List of Figures 4
Suda Ltd Snapshot 5
Suda Ltd Overview 5
Key Information 5
Key Facts 5
Suda Ltd- Research and Development Overview 6
Key Therapeutic Areas 6
Suda Ltd- Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products- Monotherapy 9
Suda Ltd- Pipeline Products Glance 10
Suda Ltd- Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Suda Ltd - Unknown Stage Pipeline Products 12
Unknown Products/Combination Treatment Modalities 12
Suda Ltd- Drug Profiles 13
sumatriptan succinate 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
sildenafil citrate 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
midazolam hydrochloride 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ondansetron hydrochloride 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
SUD-004 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Suda Ltd- Pipeline Analysis 22
Suda Ltd- Pipeline Products by Target 22
Suda Ltd- Pipeline Products by Route of Administration 23
Suda Ltd- Pipeline Products by Molecule Type 24
Suda Ltd- Pipeline Products by Mechanism of Action 25
Suda Ltd- Recent Pipeline Updates 26
Suda Ltd- Dormant Projects 28
Suda Ltd- Discontinued Pipeline Products 29
Discontinued Pipeline Product Profiles 29
ondansetron hydrochloride 29
ropinirole hydrochloride 29
Suda Ltd- Locations And Subsidiaries 30
Head Office 30

Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables

Suda Ltd, Key Information 5
Suda Ltd, Key Facts 5
Suda Ltd- Pipeline by Indication, 2014 7
Suda Ltd- Pipeline by Stage of Development, 2014 8
Suda Ltd- Monotherapy Products in Pipeline, 2014 9
Suda Ltd- Phase II, 2014 10
Suda Ltd- Phase I, 2014 11
Suda Ltd- Unknown, 2014 12
Suda Ltd- Pipeline by Target, 2014 22
Suda Ltd- Pipeline by Route of Administration, 2014 23
Suda Ltd- Pipeline by Molecule Type, 2014 24
Suda Ltd- Pipeline Products by Mechanism of Action, 2014 25
Suda Ltd- Recent Pipeline Updates, 2014 26
Suda Ltd- Dormant Developmental Projects,2014 28
Suda Ltd- Discontinued Pipeline Products, 2014 29

List of Figures

Suda Ltd - Pipeline by Top 10 Indication, 2014 7
Suda Ltd - Pipeline by Stage of Development, 2014 8
Suda Ltd - Monotherapy Products in Pipeline, 2014 9
Suda Ltd - Pipeline by Top 10 Target, 2014 22
Suda Ltd - Pipeline by Top 10 Route of Administration, 2014 23
Suda Ltd - Pipeline by Top 10 Molecule Type, 2014 24
Suda Ltd - Pipeline Products by Top 10 Mechanism of Action, 2014 25

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing